A5019339382- Gastric Cancer Management and Outcomes
- Metastasis and carcinoma case studies
- Gastrointestinal Tumor Research and Treatment
- Colorectal Cancer Surgical Treatments
- Cancer-related molecular mechanisms research
- Anorectal Disease Treatments and Outcomes
- Tracheal and airway disorders
- Anatomy and Medical Technology
- Colorectal and Anal Carcinomas
- Esophageal Cancer Research and Treatment
Peking University
2015-2025
Peking University Cancer Hospital
2015-2025
King University
2018
PURPOSE Complete mesocolic excision (CME) is being increasingly used for the treatment of right-sided colon cancer, although there still no strong evidence that CME provides better long-term oncological outcomes than D2 dissection. The controversy mainly regarding survival benefit from extended lymph node dissection emphasized by CME. METHODS This multicenter, open-label, randomized controlled trial (ClinicalTrials.gov identifier: NCT02619942 ) was performed across 17 hospitals in China....
Anastomotic leakage (AL) is a serious complication that may occur following the double stapling technique (DST). The study aims to investigate efficacy of anastomotic reinforcement using barbed sutures in preventing AL after laparoscopic low anterior resection (LAR) for rectal cancer. During period from November 1, 2018 2023, total 725 consecutive patients who had underwent LAR cancer were enrolled this study. divided into two groups: continuous suture group (N = 296) and control 429)....
Objective To investigate the clinical efficacy of laparoscopy-assisted total gastrectomy (LATG) and proximal (LAPG) in treatment adenocarcinoma esophago-gastric junction (AEG). Methods The retrospective cohort study was conducted. The clinicopathological data 130 patients with AEG who underwent radical at Peking University Cancer Hospital between May 2009 February 2016 were collected. Among patients, 91 undergoing LATG allocated into group 39 LAPG group. D2 lymph node dissection...
Background: Previous retrospective studies have shown that laparoscopic spleen-preserving D2 total gastrectomy (LSTG) for advanced upper third gastric cancer (AUTGC) is safe. However, all previous were underpowered. We therefore conducted a prospective, multicenter, single-arm, phase II study to evaluate the feasibility of LSTG in patients with AUTGC.